| pubmed-article:10231009 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10231009 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:10231009 | lifeskim:mentions | umls-concept:C0018850 | lld:lifeskim |
| pubmed-article:10231009 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
| pubmed-article:10231009 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:10231009 | pubmed:dateCreated | 1999-7-21 | lld:pubmed |
| pubmed-article:10231009 | pubmed:abstractText | Adjuvant arthritis (AA) is a frequently used model of experimental arthritis. Because of its histopathology, which is reminiscent of rheumatoid arthritis in humans, AA is used as a model for the development of novel anti-inflammatory drugs. Recently, it has become evident that AA is a typical T-cell-mediated autoimmune condition. Therefore, novel immunotherapies targeted to T cells can be developed in this model. Analysis of responding T cells in AA have now led to the definition of various antigens with potential relevance to arthritis, including human arthritic conditions. One such antigen defined in AA is the 60kD heat shock protein. Both T-cell vaccination approaches and active antigen immunizations and antigen toleration approaches have turned out to be effective in suppressing AA. | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10231009 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10231009 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10231009 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10231009 | pubmed:issn | 1064-7449 | lld:pubmed |
| pubmed-article:10231009 | pubmed:author | pubmed-author:van EdenWW | lld:pubmed |
| pubmed-article:10231009 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10231009 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:10231009 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10231009 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10231009 | pubmed:pagination | 49-54 | lld:pubmed |
| pubmed-article:10231009 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:10231009 | pubmed:meshHeading | pubmed-meshheading:10231009... | lld:pubmed |
| pubmed-article:10231009 | pubmed:meshHeading | pubmed-meshheading:10231009... | lld:pubmed |
| pubmed-article:10231009 | pubmed:meshHeading | pubmed-meshheading:10231009... | lld:pubmed |
| pubmed-article:10231009 | pubmed:meshHeading | pubmed-meshheading:10231009... | lld:pubmed |
| pubmed-article:10231009 | pubmed:meshHeading | pubmed-meshheading:10231009... | lld:pubmed |
| pubmed-article:10231009 | pubmed:meshHeading | pubmed-meshheading:10231009... | lld:pubmed |
| pubmed-article:10231009 | pubmed:meshHeading | pubmed-meshheading:10231009... | lld:pubmed |
| pubmed-article:10231009 | pubmed:meshHeading | pubmed-meshheading:10231009... | lld:pubmed |
| pubmed-article:10231009 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10231009 | pubmed:articleTitle | Immunity to heat shock proteins and arthritic disorders. | lld:pubmed |
| pubmed-article:10231009 | pubmed:affiliation | Institute of Infectious Diseases and Immunology, Utrecht University, The Netherlands. w.eden@vet.uu.nl | lld:pubmed |
| pubmed-article:10231009 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10231009 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10231009 | lld:pubmed |
